Psychiatry and Psychology [F] » Mental Disorders [F03] » Sleep Wake Disorders » Dyssomnias » Sleep Disorders, Intrinsic » Disorders of Excessive Somnolence » Narcolepsy
Diseases [C] » Nervous System Diseases [C10] » Sleep Wake Disorders » Dyssomnias » Sleep Disorders, Intrinsic » Disorders of Excessive Somnolence » Narcolepsy
Description
A condition characterized by recurrent episodes of daytime somnolence and lapses in consciousness (microsomnias) that may be associated with automatic behaviors and AMNESIA. CATAPLEXY; SLEEP PARALYSIS, and hypnagogic HALLUCINATIONS frequently accompany narcolepsy. The pathophysiology of this disorder includes sleep-onset rapid eye movement (REM) sleep, which normally follows stage III or IV sleep. (From Neurology 1998 Feb;50(2 Suppl 1):S2-S7) MeSH
Hierarchy View
Subtype Terms (1)
Cataplexy
4 drugs (3 approved, 1 experimental)
Phase 3 Indicated Drugs (2)
Phase 2 Indicated Drugs (8)
Other Experimental Indicated Drugs (2)
Organization Involved with Phase 4 Indications (2)
Organization Involved with Phase 3 Indications (4)
Organization Involved with Phase 2 Indications (17)
Organization Involved with Phase 1 Indications (7)
Organization Involved with Other Experimental Indications (6)
Hierarchy Tree View
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
